108 related articles for article (PubMed ID: 29317218)
1. DLX1, a binding protein of beta-catenin, promoted the growth and migration of prostate cancer cells.
Liang M; Sun Y; Yang HL; Zhang B; Wen J; Shi BK
Exp Cell Res; 2018 Feb; 363(1):26-32. PubMed ID: 29317218
[TBL] [Abstract][Full Text] [Related]
2. NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells.
Gu S; Hou P; Liu K; Niu X; Wei B; Mao F; Xu Z
Chem Biol Interact; 2018 Oct; 294():40-47. PubMed ID: 30125550
[TBL] [Abstract][Full Text] [Related]
3. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells.
Wang Z; Sun P; Gao C; Chen J; Li J; Chen Z; Xu M; Shao J; Zhang Y; Xie J
Exp Cell Res; 2017 Aug; 357(1):1-8. PubMed ID: 28408316
[TBL] [Abstract][Full Text] [Related]
5. CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma.
Duan J; He Y; Fu X; Deng Y; Zheng M; Lu D
Exp Cell Res; 2018 Sep; 370(2):461-467. PubMed ID: 29981747
[TBL] [Abstract][Full Text] [Related]
6. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F
Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520
[TBL] [Abstract][Full Text] [Related]
7. Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells.
Dai Y; Wang M; Wu H; Xiao M; Liu H; Zhang D
Oncotarget; 2017 Feb; 8(6):9783-9793. PubMed ID: 28039460
[TBL] [Abstract][Full Text] [Related]
8. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
Sun P; Xiong H; Kim TH; Ren B; Zhang Z
Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872
[TBL] [Abstract][Full Text] [Related]
9. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
[TBL] [Abstract][Full Text] [Related]
10. Frequently rearranged in advanced T‑cell lymphomas‑1 demonstrates oncogenic properties in prostate cancer.
Zhang W; Xiong H; Zou Y; Xu S; Quan L; Yuan X; Xu N; Wang Y
Mol Med Rep; 2016 Oct; 14(4):3551-8. PubMed ID: 27599661
[TBL] [Abstract][Full Text] [Related]
11. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
Wang D; Lu G; Shao Y; Xu D
Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
[TBL] [Abstract][Full Text] [Related]
12. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
13. WWC3 Inhibits Glioma Cell Proliferation Through Suppressing the Wnt/β-Catenin Signaling Pathway.
Wang Y; Jiang M; Yao Y; Cai Z
DNA Cell Biol; 2018 Jan; 37(1):31-37. PubMed ID: 29115863
[TBL] [Abstract][Full Text] [Related]
14. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.
Chan DW; Hui WW; Wang JJ; Yung MM; Hui LM; Qin Y; Liang RR; Leung TH; Xu D; Chan KK; Yao KM; Tsang BK; Ngan HY
Oncogene; 2017 Mar; 36(10):1404-1416. PubMed ID: 27593933
[TBL] [Abstract][Full Text] [Related]
15. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
[TBL] [Abstract][Full Text] [Related]
16. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
18. TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells.
Debelec-Butuner B; Alapinar C; Ertunc N; Gonen-Korkmaz C; Yörükoğlu K; Korkmaz KS
PLoS One; 2014; 9(10):e109868. PubMed ID: 25360740
[TBL] [Abstract][Full Text] [Related]
19. TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer.
Yuedi D; Yuankun C; Jiaying Z; Han L; Yueqi W; Houbao L; Dexiang Z
Oncotarget; 2017 Sep; 8(41):70538-70549. PubMed ID: 29050300
[TBL] [Abstract][Full Text] [Related]
20. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
